This topic contains a solution. Click here to go to the answer

Author Question: During therapy with hematopoietic drugs, the nurse will monitor the patient for which adverse ... (Read 38 times)

littleanan

  • Hero Member
  • *****
  • Posts: 575
During therapy with hematopoietic drugs, the nurse will monitor the patient for which adverse effects?
 
  (Select all that apply.)
  a. Hypotension
  b. Edema
  c. Diarrhea
  d. Black, tarry stools
  e. Nausea and vomiting
  f. Headache

Question 2

A patient must be treated immediately for acute organ transplant rejection.
 
  The nurse anticipates that muromonab-CD3 (Orthoclone OKT3) will be ordered. What is the priority assessment before beginning drug therapy with muromonab-CD3?
  a. Serum potassium level
  b. Fluid volume status
  c. Electrocardiogram
  d. Blood glucose level



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

hanadaa

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

ANS: B, C, E, F

Answer to Question 2

ANS: B




littleanan

  • Member
  • Posts: 575
Reply 2 on: Jul 23, 2018
:D TYSM


miss_1456@hotmail.com

  • Member
  • Posts: 289
Reply 3 on: Yesterday
Excellent

 

Did you know?

Medications that are definitely not safe to take when breastfeeding include radioactive drugs, antimetabolites, some cancer (chemotherapy) agents, bromocriptine, ergotamine, methotrexate, and cyclosporine.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

For a complete list of videos, visit our video library